For the Inventor, By the Inventor

Enter assignee name

Monmouth Junction, NJ, United States of America

Cytosorbents Corporation

Calculating rank

USPTO Granted Patents = 30

% Expired Patents = 10.0

EPO Patents = 10

Trademarks = 6

Forward Citations = 41

Loading Chart...

Loading Chart...

30 inventors (with patents filed for the assignee):

Thomas D Golobish (24 out of 28 patents)

Vincent J Capponi (22 out of 24 patents)

Phillip Chan (19 out of 19 patents)

4. Wei-Tai Young (15 out of 16 patents)

5. Humayra Begum Ali (12 out of 12 patents)

6. Tamaz Guliashvili (8 out of 11 patents)

7. Andrew Scheirer (8 out of 8 patents)

8. Maryann Gruda (7 out of 10 patents)

9. Pamela O'Sullivan (6 out of 6 patents)

10. James A Brady (4 out of 9 patents)

11. Vadim Davankov (4 out of 24 patents)

12. Ludmila Pavlova (4 out of 17 patents)

13. Frank M Norris (4 out of 7 patents)

14. Peter J Quartararo, Jr (4 out of 7 patents)

15. Jamie A Salsberg (4 out of 7 patents)

Core Competencies:

Hemocompatible Polymers

Toxin Removal

Inflammation Treatment

Biocompatible Beads

Polymeric Sorbents

Extracorporeal Circuit

Radiation Induced Mucositis

Size-Selective Hemoperfusion

Blood Contamination Reduction

Protein Based Toxins

Crosslinked Polysaccharides

Endotoxemia-Inducing Molecules

30 patents: Sort by Forward Citations

1. 12280196 - Methods of using polymers (2025-04-21),

2. 12208116 - Multi-functional hemocompatible porous bead sorbent for removing protein based toxins and potassium from biological fluids (2025-01-28),

3. 12121879 - Crosslinked polysaccharide based absorbents for removal of anti-A and/or anti-B antibodies from human plasma and whole blood (2024-10-22),

4. 12076474 - Method of treating traumatic brain injury (2024-09-03),

5. 11969535 - Connector assembly and methods of use (2024-04-30),

6. 11826724 - Use of a hemocompatible porous polymer bead sorbent for removal of endotoxemia-inducing molecules (2023-11-28),

7. 11752250 - Hemocompatibility modifiers for cross-linked polymeric material (2023-09-12),

8. 11723916 - Multi-functional hemocompatible porous polymer bead sorbent for removing protein based toxins and potassium from biological fluids (2023-08-15),

9. 11602585 - Methods for reducing contamination in a biological substance (2023-03-14),

10. 11202855 - Methods for removal of toxins from blood using an extracorporeal circuit comprised of a hollow-fiber filter module and polymer sorbent in combination (2021-12-21),

11. 11065600 - Use of a hemocompatible porous polymer bead sorbent for removal of endotoxemia-inducing molecules (2021-07-20),

12. 11058715 - Method of treating inflammation (2021-07-13),

13. 11040061 - Multi-functional hemocompatible porous polymer bead sorbent for removing protein based toxins and potassium from biological fluids (2021-06-22),

14. 11020521 - Hemocompatibility modifiers for cross-linked polymeric material (2021-06-01),

15. 10967001 - Method of treating inflammation (2021-04-06),

Company Overview

Cytosorbents Corporation, based in Monmouth Junction, NJ, specializes in developing innovative medical technologies aimed at treating life-threatening conditions. The company is particularly known for its blood purification therapies, which utilize advanced adsorption techniques to remove harmful substances from the bloodstream. Its primary focus is on critical care and cardiac surgery applications, positioning it as a leader in the field of extracorporeal blood treatment solutions. Cytosorbents is committed to improving patient outcomes through its cutting-edge research and development efforts.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

30 Patents

#5 in Monmouth Junction, NJ

#451 in New Jersey

#11,288 in US

#21,924 in the World

Monmouth Junction, NJ, United States of America

Cytosorbents Corporation

Forward Citations = 41

30 inventors:

Thomas D Golobish (24 out of 28 patents)

Vincent J Capponi (22 out of 24 patents)

Phillip Chan (19 out of 19 patents)

4. Wei-Tai Young (15 out of 16 patents)

5. Humayra Begum Ali (12 out of 12 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cytosorbents Corporation. Retrieved from https://idiyas.com/company/cytosorbents

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…